Author Guidelines

Manuscript Category

Innova Science invites scholarly articles including full-length research papers, brief articles, commentaries, letters, case-studies, perspectives, reviews and mini-reviews. Theme-based articles are also invited. Special issues include invited review/mini-review articles written in English from leading scientists which are peer-reviewed for publication. Authors interested in editing a special issue on an emerging topic are encouraged to submit their proposals to the Editor-in-Chief of the respective journal for consideration.

For proposals to publish conference papers and proceedings, please contact Innova Science at the email address:

Manuscript Length

There is no restriction on the word limit and the number of pages, figures and tables for full research articles, case-studies, theme-based articles and reviews. Mini-reviews are within the limit of 10 journal pages (40-double spaced pages), brief articles and short theme-based articles within 6 journal pages (24- double spaced pages), letters and perspectives within 4 journal pages (16-double spaced pages) that include figures, schemes, tables and references. All supporting relevant data for the research articles should be included in a supplementary section.

Manuscript preparation and organization

The manuscript is to be prepared in Microsoft word and written clearly in the English language. The manuscript style must be uniform and double spaced throughout the text and a 12 pt Times New Roman font should be used. Binomial names of organisms (genus and species) and non-assimilated words e.g. per se, et al. etc. should be in italics.

All the figures, schemes and tables should be placed in sequential order after the reference section of the manuscript and their placement in the text should be indicated appropriately. It is the responsibility of the authors to make sure that the manuscript does not contain any plagiarized material and the English language is of an acceptable standard.

The manuscript is organized in the following sequence: Title page, abstract, introduction, results and discussion, conclusion, experimental, acknowledgements, conflicts of interest, abbreviations and references.

A supplemental section containing all supporting relevant data for the research article should be included after the reference section.

Manuscript Main Page

Manuscript Title:The title accurately describes the content of the scholarly work. It should be precise and focused.

Authorship:It includes the individuals who are involved in the research work and have intellectually contributed to the study in accordance with the guidelines of the International Committee of Medical Journal Editors ( that includes four criteria that each author of a paper should meet: (1) Significant involvement in study conception/design, data collection, or data analysis/interpretation; (2) Involvement in drafting or revising manuscript; (3) Approval of the final version of the manuscript for publication; and (4) Responsibility for accuracy and integrity of all aspects of research. Guest or honorary authorships are discouraged.

The name of the authors in the manuscript should be in the order as it will appear in the final publication. The corresponding author(s) name is indicated by an asterisk (*). The order of the author’s name cannot be changed at a later stage without any valid reasons and permission approved by the Editorin Chief of the journal.

Affiliations of the authors:For more than one affiliation, they are numbered as 1,2,3… . and indicated with the names as superscripts. The author’s primary affiliation is the institution where the author is involved in the study. If the author is on leave from the primary institution to pursue research at another institution, the author’s primary institution needs to be acknowledged in the acknowledgement section.

Corresponding author(s):The article may include more than one corresponding author. The e-mail address and telephone number of the corresponding author(s) should be provided.


The abstract of the article provides an insight as to the objective of the study and gives an overall summary including conclusions of the study. It should be within a limit of 200-250 words.


At least 5 important keywords to be provided.


The Introduction section includes a comprehensive discussion of the background and the relevant literature and aims of the research study.

Results and Discussion

The results of the study are described in detail. The discussion part is built on the analysis of the results of the study and should emphasize the outcomes in the light of the objectives of the study and recent developments in the field. The discussion of literature reports and related published work discussed in this section should be limited and appropriately cited.


The conclusion section summarizes the final outcome of the proposed study and also provides some directions for future study.


The experimental section includes the source of the materials and details of the methodologies used in the study. If a literature procedure is used, a brief discussion of the methodology along with a literature reference should be cited. All kinds of measurements are reported only in the International System of Units (SI). Authors must report any unexpected and significant hazards or risks associated with the experimental work in the experimental section of the article.


The study supported by all funding sources of each author must be acknowledged. Several roles that merit acknowledgement include general supervision of a research group or general administrative support and writing assistance, technical editing, language editing, and proof-reading as described by The International Committee of Medical Journal Editors (

Conflicts of Interest

Authors must declare potential conflicts of interest either personal or financial. A statement describing all potential sources of conflicts, including affiliations, funding sources, and financial or management relationships, must be provided in this section of the manuscript which will be published in the final article. If no conflict of interest is declared, the following statement will be published in the article: “The authors declare no competing conflicts of interest.”


An abbreviation is a shortened form of a word or phrase. An abbreviation used in the text should be explained where it was used first. A list of abbreviations can be provided before the reference section.


The references are numbered in the sequential order [as superscripts] in the text and listed in the same numerical order in the reference section. All references must be accurate and are from reliable literature sources. The formatting of the references should be according to the following style.

Journal paper

Wang, X. L., Xing, B. S. Sorption of organic contaminates by biopolymer-derived chars. Environ. Sci. Technol. 2007, 41, 8342-8348.


Dimmock, J. R., Das, U. Antineoplastic compounds. U.S. Patent 7,582,655, Sep. 1, 2009.

Book Chapter

Kumar, S., Das, U., Dimmock, J., Sharma, R. K. Role of proteases in the regulation of Nmyristoyltransferase. In: Proteases in Physiology and Pathology (Eds.Chakraborty, S., Dhalla, N. S.), Springer, 2016, 89-99.


Choudhary, M. I., Thomsen, W. J. Bioassay techniques for drug development. CRC Press, 2003.


Mukker, J. K. Pharmacokinetic and pharmacodynamic studies on flaxseed lignans. Ph.D. Thesis,University of Saskatchewan, Saskatoon, Jan. 2013.

The manuscript that has been formally accepted for publication by a journal but not yet been published online should be listed as “in press”. For manuscripts that have been accepted for publication and is available online, a DOI number should be provided. The results that have not been published yet should be listed as “unpublished results”.

Supporting Information

A separate word file containing Supplementary Material must be sequentially numbered and referred to in the manuscript. Authors must clearly indicate if these files are meant for publication or for the reviewers'/editors' perusal only.

Graphical Abstract

A graphical abstract summarizing the objectives and the results of the study should be provided in a concise pictorial form. It may include a figure, structure or a chemical reaction, etc. The graphical abstract should be specified within an area of 20 cm (wide) x 6 cm (high). It will be listed in the Table of Contents (TOC) page along with the manuscript title and authors’ names. It should be supplied as a separate image or PDF file.


Good quality figures and high resolution images in JPEG or TIFF file format are required for publication. The figures supplied in colour will be published in colour only. Consistent letter sizing and graphics labels throughout the manuscript are required to ensure consistent graphic presentation for publication. For the image files, the following minimum resolutions are required: black and white line art (1200 dpi), grayscale art (600 dpi) and color art (300 dpi). The graphics should be sized either as a single column graphics (width 3.5 inches) or a double column graphics (7 inches).

The figures must include illustrations which are numbered consecutively in the order of their placement. Once the manuscript is accepted for publication, authors will be asked to provide original figures/photographs in JPEG or TIFF file format.

Chemical Structures

Chemical structures and schemes must be drawn using a structure drawing software such as Chemdraw or ISIS draw as per the following specifications:

Preference setting:Units (points) and tolerance (3 pixel)

Drawing setting:Chain angle (120o), bond spacing (18%), bold width (2.0 pt), line width (0.6 pt), margin width (1.6 pt), hash spacing (2.5 pt).

Text setting:Font (Times New Roman) and size (8 pt)

Page setting:Paper (US letter) and scale (100%)

If the structures are sub-standard, the authors will be asked to improve the same. Innova Science offers the option of improving the structures professionally through a third party provider. The costs for such improvement will be charged to the authors.


Tables are prepared in Microsoft Word table format. Each table includes a brief title/caption with only the first letter in caps, a period at the end of the caption and the numbers are in bold letters as illustrated in the example below.

Table 1. Antifungal evaluation of the compounds in the series 1-15.

Tables are numbered sequentially in Arabic numerals in order of their placement in the text. A footnote should be provided at the end of the table if any references are cited in the table and the table caption. The references should be numbered in order as per their placement of the table in the main body text.

Manuscript Submission

The manuscripts are submitted electronically using our online manuscript submission portal. An auto-generated acknowledgement with a manuscript identification number will be received by the author following successful electronic submission of a manuscript. Any queries regarding the manuscript afterwards should be directed to

Manuscript submission can be made by any one of the authors of the manuscript. The manuscripts submitted by any other person on behalf of the authors will not be considered. The principal/corresponding author is the primary contact during the article review and publication process.

The corresponding author will be held accountable for any unethical issues relating to the manuscript. Only the original article that has not been published previously or the article is not currently under consideration elsewhere will be considered for publication. If any part of the manuscript has been published previously, it must be cited with a proper reference and a copyright permission must be obtained from the copyright holder of the article.

Authors need to ensure that the figure legends and captions are included and the figures, tables, chemical structures, reference etc. are referred to in the text appropriately where they have been first discussed.

For all online submissions, a covering letter, graphical abstract and the manuscript containing all the structures / figures / illustrations / tables and supporting information should be provided.

Editorial Policies

The editorial policies including publication ethics, peer-review processes, plagiarisms, copyrights/ licenses, and article retraction/withdrawal can be viewed under the quick links section of Innova Science Publishers website (

Publication Charges

Innova Science supports both subscription and optional open access article publication models. There are no publication fees paid by the authors for publishing in Innova journals in its subscriptionbased model. However, for the open access articles publication charges apply. The article publication charges (PAC) for the subscription articles are supported by subscribing institutions or individuals. Innova Science offers subscription pricing for each of these publication separately.

Open access articles are funded by payments made by authors, their institution or funding organizations. The open access fee may vary for each article for publication in any of the Innova Journals. Authors may be granted discounts on the Open Access fee if the author’s institution has subscribed to the respective Innova journal or applied for a subscription to the journal.

English Language, Art Works, Images and Structures

Authors should ensure that the articles submitted to Innova Journals has been checked for good English as well as good quality structures and art works. The articles containing grammatical mistakes, typographical errors, and language inconsistencies and poor quality figures, structures and art works will be returned to the authors for language editing and improving figures/structures/art works.

Innova Science can assist authors in language editing, preparing the art works and structures through its collaborative partners. The costs for such improvement will be charged to the authors. For author services please e-mail at

Galley Proof Corrections

The corresponding author(s) will receive a galley proof of their accepted paper before publication. The proof should be checked promptly by the authors for typographical errors and returned to the editorial office within 72 hours. Major changes are not acceptable at the proof stage. If the proof corrections cannot be returned within 72 hours due to some unavoidable circumstances, the corresponding author or any of the authors must contact the editorial office for an extension for returning the galley proof of the article. The article will be published exactly as received after corrections in the galley proof and the publishers will not be responsible for any error occurring in the published manuscript in this regard.

The corresponding author is solely responsible for ensuring that the revised version of the manuscript incorporating corrections is approved by all the co-authors of the manuscript.


All Innova Journals are published electronically. No paper prints are available to order. Author(s) may order a free pdf copy of the article from the Publisher after publication of the article if the author’s institution has subscribed to the respective Innova Journal. Publishing author(s) or their institution may subscribe to the journal at 50% of the normal subscription rate by contacting the editorial office at e-mail:

Patents and Intellectual Property

The article publication will not be delayed for any pending or unresolved patent and intellectual property issues. These issues must be resolved before publication of the article.

Professional Ethics

Authors, reviewers and editors must adhere to the following ethical guidelines.

Author Consent

The corresponding author or the submitting author must obtain the consent of all coauthors prior to submission of manuscripts.


The submitted manuscripts must be original in terms of its study concept, content, and writing. Authors should not use any content in full or in part from any other articles. Articles containing any plagiarized materials will not be considered for publication. Any plagiarized content found in the published article will be retracted. The corresponding author will remain responsible for all actions relating to this matter.

Use of Animal or Human Subjects

Experiments involving animals must be conducted in accordance with institutional and regulatory guidelines in their respective countries. Authors must include a declaration of compliance with relevant guidelines and regulations and the standards and procedures mentioned in the Guide for the Care and Use of Laboratory Animals ( prepub.pdf). The authors must clearly indicate the name of the approval committee and provide a statement in the manuscript that legal and ethical approvals were obtained prior to the initiation of the research work involving animals.

For all clinical investigations, the authors must comply with the guidelines of the International Committee of Medical Journal Editors ( with regard to a patient’s consent for research or participation in a study. Authors should obtain written and signed consent from the patients for the use of information including photographs and videos in any published work including Journal, derivative works, or on the journal’s website. Patient personal information should not be used in the manuscript. Editors may ask the authors to provide a copy of the relevant documentation approved by the ethics or institutional review committee.

For investigations on plants involving field studies, the authors should include a declaration of compliance with relevant international guidelines and/or relevant permissions or licences obtained by the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

Specialized Experimental Data
Purity of Test Compounds

For establishing purity of the target compounds, all established methodologies (e.g., HPLC, combustion analysis, 1H NMR, high resolution mass spectrometry) are acceptable. All target compounds should possess a purity of more than 95%. Compounds with less than 95% pure may be considered in exceptional cases. The melting point or melting point range of the test compounds should be recorded and reported as an indicator of purity. Elemental analysis results (carbon, hydrogen, nitrogen and sulphur) should be within 0.5 % of the calculated values. The deuterated solvent used for 1H and 13C NMR and the magnetic field strength of the NMR machine should be mentioned (e.g. 1H NMR (CDCl3, 500 MHz). Specific rotations of enantiomeric pure compounds, and enantiomer mixtures should be mentioned as per the equation [α] = (100α)/(lc) as unitless numbers (e.g. [α] 30D 25 (c 1.9, MeOH), where the concentration c is in g/l00 mL and the path length l is in decimeters.

Biological Data

Biological methods should be described in detail in the experimental section of the manuscript and the test methods must be properly referenced where applicable. Quantitative biological data for all tested compounds must be presented. The cell line must be tested for Mycoplasma contamination and the cell line source must be indicated. The experimental section should include the number of replicates and independent experiments performed to test the compounds to generate biological data. Concentrations are to be expressed as molar quantities (e.g., μM, nM) and animal doses expressed in weight/weight (e.g., mg/kg). The routes of administration of test compounds and vehicles used should be mentioned. The physical state of the test compound administered (e.g. solid, solution, suspension), its formulation for dosing (e.g. micronized, nanoparticles) and the use of any salt forms of the test compound (e.g. hydrochlorides, sulfates, etc.) should be mentioned.


Details of the software used in the research study should be mentioned (e.g. source, year). An URL link to the software source should be acknowledged.

Structural Data

For biological macromolecules, the atomic coordinates and the related experimental data must be deposited at a member site of the Worldwide Protein Data Bank ( Any questions related to deposits should be sent to Examples of some of the protein data banks are: RCSB PDB (, BMRB (, Protein Databank in Europe (PDBe) (, PDBj ( The PDB ID must be mentioned in the experimental part and referred in the text. The authors must release the atomic coordinates and experimental data once the article has been published. For the structure and coordinates of a protein that has already been reported in the database, the article should indicate the PDB ID as a reference.

For X-ray diffraction structures of small molecules, a figure displaying the thermal ellipsoids or a spherical-atom representation should be submitted for publication. A view of the unit cell may be presented in the structures where intermolecular interactions are relevant. The experimental section should include the structural formula, molecular weight, crystal system, space group, unit cell parameters, temperature of data collection, and values of Z, R, and GOF. The tables of atom coordinates and thermal parameters may be presented in the supporting information. The CIF files must be submitted to the Cambridge Crystallographic Data Centre (CCDC).

Journal Publishing Agreement

A completed and signed Journal Publishing Agreement must be submitted to Innova Science for each manuscript by the corresponding author on behalf of all authors before the publication of the article. If the corresponding author cannot complete the journal publishing agreement, any one of the authors should complete and sign the document on behalf of all the authors. Innova Science will provide an electronic version of the Journal Publishing Agreement for the accepted manuscripts before publication.

Expressions of Concern

Expressions of concern will be dealt with in accordance with the Committee on Publication Ethics (COPE) guidelines which states that expressions of concern may be issued if:

  • there is inconclusive evidence of research or publication misconduct by the authors;
  • there is evidence that the findings are unreliable but the authors’ institution will not investigate the case;
  • an investigation into alleged misconduct related to the publication either has not been, or would not be, fair and impartial or conclusive;
  • an investigation is underway but a judgment will not be available for a considerable time.

Expressions of concern are taken seriously and an investigation will be conducted at the discretion of the Editor-in-Chief. Upon completion of any such investigations, a retraction notice or correction will be published.

Article Retractions

Articles that contain plagiarized content or seriously flawed data will result in an investigation which will be initiated at the discretion of the Editor-in-Chief. If any unethical misconduct is established, the article would be retracted. A notice of retraction of the article will be published containing information about the original article title, author list, and the reason for the retraction. Retracted articles will be marked as “Retracted”. The originally published article will remain on the Web except in extraordinary circumstances.

End User Terms and Conditions

Innova Science Publishers Inc. (or its licensors) owns the copyright of the Article. The author(s) are allowed to use the articles and access the articles from the publisher’s website as per the terms and conditions set out by Innova Science for academic purposes and the author(s) are not permitted to use the articles for any commercial or business use. As per the publishing agreement, authors are not allowed to share the copy of their article published with Innova Science on social/electronic media or with any other second party without prior permission from the publisher. By accessing the articles via the website authors agree to be bound by these Terms.